Literature DB >> 7613557

Poisson regression analysis in clinical research.

F Kianifard1, P P Gallo.   

Abstract

Generalized linear models (GLM) are now widely used in analyzing data from clinical trials and in epidemiological studies. In Poisson regression, which fits in the framework of a GLM, the response variable is a count that follows the Poisson distribution. This article describes the basic methodology of Poisson regression analysis and its application to clinical research. Overdispersion, model diagnostics, and sample size issues are discussed. The methodology is illustrated on a data set from a clinical trial for the treatment of bladder cancer, using a new procedure (PROC GENMOD) in the statistical package SAS.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7613557     DOI: 10.1080/10543409508835101

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  8 in total

1.  Conditional modeling of antibody titers using a zero-inflated poisson random effects model: application to Fabrazyme.

Authors:  Peter L Bonate; Crystal Sung; Karen Welch; Susan Richards
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-09-30       Impact factor: 2.745

2.  The impact of trauma exposure and post-traumatic stress disorder on healthcare utilization among primary care patients.

Authors:  Anand Kartha; Victoria Brower; Richard Saitz; Jeffrey H Samet; Terence M Keane; Jane Liebschutz
Journal:  Med Care       Date:  2008-04       Impact factor: 2.983

Review 3.  The utility of modeling and simulation approaches to evaluate immunogenicity effect on the therapeutic protein pharmacokinetics.

Authors:  Juan Jose Perez Ruixo; Peiming Ma; Andrew T Chow
Journal:  AAPS J       Date:  2012-11-10       Impact factor: 4.009

4.  Exploring the dynamics and interplay of human papillomavirus and cervical tumorigenesis by integrating biological data into a mathematical model.

Authors:  Wenting Wu; Lei Song; Yongtao Yang; Jianxin Wang; Hongtu Liu; Le Zhang
Journal:  BMC Bioinformatics       Date:  2020-05-05       Impact factor: 3.169

5.  A novel approach to medicines optimisation post-discharge from hospital: pharmacist-led medicines optimisation clinic.

Authors:  Mohanad Odeh; Claire Scullin; Anita Hogg; Glenda Fleming; Michael G Scott; James C McElnay
Journal:  Int J Clin Pharm       Date:  2020-06-11

6.  Local Characteristics Related to SARS-CoV-2 Transmissions in the Seoul Metropolitan Area, South Korea.

Authors:  Changmin Im; Youngho Kim
Journal:  Int J Environ Res Public Health       Date:  2021-11-29       Impact factor: 3.390

7.  Population Landscape of Familial Cancer.

Authors:  C Frank; M Fallah; J Sundquist; A Hemminki; K Hemminki
Journal:  Sci Rep       Date:  2015-08-10       Impact factor: 4.379

8.  Impact of a Large Fire and Subsequent Pollution Control Failure at a Coke Works on Acute Asthma Exacerbations in Nearby Adult Residents.

Authors:  Tricia L Morphew; Arvind Venkat; John Graham; Matthew Mehalik; Norman Anderson; Deborah Gentile
Journal:  Toxics       Date:  2021-06-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.